Practical synthesis and SAR study of aliskiren: An orally active human renin inhibitor

被引：0
|
作者：
Dong, Hua [1 ]
Zhang, Zhi-Liu [1 ]
Huang, Lia-Hui [1 ]
Ma, Rujian [1 ]
Chen, Shu-Hui [1 ]
Li, Ge [1 ]
机构：
[1] WuXi PharmaTech Co Ltd, Shanghai 200131, Peoples R China
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 230卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
341-MEDI
引用
收藏
页码：U2696 / U2696
页数：1
相关论文
共 50 条
  • [11] AN ORALLY-ACTIVE INHIBITOR OF RENIN
    PALS, DT
    THAISRIVONGS, S
    LAWSON, JA
    KATI, WM
    TURNER, SR
    DEGRAAF, GL
    HARRIS, DW
    JOHNSON, GA
    HYPERTENSION, 1986, 8 (09) : 833 - 833
  • [12] Aliskiren - an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension
    Allikmets, Kristina
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (06) : 809 - 815
  • [13] Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100) - Comparison with enalapril
    Nussberger, J
    Wuerzner, G
    Jensen, C
    Brunner, HR
    HYPERTENSION, 2002, 39 (01) : E1 - E8
  • [14] Structure-based design of aliskiren, a novel orally effective renin inhibitor
    Wood, JM
    Maibaum, J
    Rahuel, J
    Grütter, MG
    Cohen, NC
    Rasetti, V
    Rüger, H
    Göschke, R
    Stutz, S
    Fuhrer, W
    Schilling, W
    Rigollier, P
    Yamaguchi, Y
    Cumin, F
    Baum, HP
    Schnell, CR
    Herold, P
    Mah, R
    Jensen, C
    O'Brien, E
    Stanton, A
    Bedigian, MP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (04) : 698 - 705
  • [15] A NOVEL NONPEPTIDIC, ORALLY ACTIVE RENIN INHIBITOR
    MORISHIMA, H
    KOIKE, Y
    NAKANO, M
    ATSUUMI, S
    TANAKA, S
    FUNABASHI, H
    HASHIMOTO, J
    SAWASAKI, Y
    MINO, N
    NAKANO, M
    MATSUSHIMA, K
    NAKAMICHI, K
    YANO, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 159 (03) : 999 - 1005
  • [16] MACROCYCLIC RENIN INHIBITORS - SYNTHESIS OF A SUBNANOMOLAR, ORALLY ACTIVE CYSTEINE DERIVED INHIBITOR
    YANG, LH
    WEBER, AE
    DOYLE, JJ
    SCHORN, TW
    SIEGL, PKS
    HALGREN, TA
    GREENLEE, WJ
    PATCHETT, AA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 122 - MEDI
  • [17] Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals
    Richter, WF
    Whitby, BR
    Chou, RC
    XENOBIOTICA, 1996, 26 (03) : 243 - 254
  • [18] Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan
    Pool, James L.
    Schmieder, Roland E.
    Azizi, Michel
    Aldigier, Jean-Claude
    Januszewicz, Andrzej
    Zidek, Walter
    Chiang, Yanntong
    Satlin, Andrew
    AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (01) : 11 - 20
  • [19] MACROCYCLIC RENIN INHIBITORS - SYNTHESIS OF A SUBNANOMOLAR, ORALLY-ACTIVE CYSTEINE DERIVED INHIBITOR
    YANG, LH
    WEBER, AE
    GREENLEE, WJ
    PATCHETT, AA
    TETRAHEDRON LETTERS, 1993, 34 (44) : 7035 - 7038
  • [20] FK-906, A HIGHLY POTENT, ORALLY-ACTIVE HUMAN RENIN INHIBITOR
    NEYA, M
    MARUSAWA, H
    IMAL, K
    KAYAKIRI, N
    WATANABE, S
    HEMML, K
    HASHIMOTO, M
    TANAKA, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 56 - MEDI
12345